TP53 R248Q TCR-T Cell Therapy for Advanced Solid Tumor

Clinical trial NCT06619886 · NOT_YET_RECRUITING

Trial details

NCT number: NCT06619886
Sponsor: Shanghai General Hospital, Shanghai Jiao Tong University School of Medicine
Status: NOT_YET_RECRUITING
Phase: Early Phase 1
Study type: INTERVENTIONAL

Solid Tumor, Adult Lung Adenocarcinoma Pancreas Cancer Colorectal Cancer Other Solid Tumor

Start date: 2024-09-24
Primary completion: 2026-10-31
Enrollment: 9

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.